4.7 Article

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up

Jose-Ezequiel Martin et al.

HUMAN MOLECULAR GENETICS (2012)

Article Rheumatology

PTPN22 R620W polymorphism in the ANCA-associated vasculitides

Davide Martorana et al.

RHEUMATOLOGY (2012)

Article Rheumatology

Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis

L. M. Diaz-Gallo et al.

ANNALS OF THE RHEUMATIC DISEASES (2011)

Article Rheumatology

The PTPN22 R263Q Polymorphism Is a Risk Factor for Rheumatoid Arthritis in Caucasian Case-Control Samples

Luis Rodriguez-Rodriguez et al.

ARTHRITIS AND RHEUMATISM (2011)

Review Immunology

Pathogenesis of giant cell arteritis: More than just an inflammatory condition?

Kim-Heang Ly et al.

AUTOIMMUNITY REVIEWS (2010)

Article Cardiac & Cardiovascular Systems

Th17 and Th1 T-Cell Responses in Giant Cell Arteritis

Jiusheng Deng et al.

CIRCULATION (2010)

Review Rheumatology

Epidemiology of Giant Cell Arteritis and Polymyalgia Rheumatica

Miguel A. Gonzalez-Gay et al.

ARTHRITIS CARE & RESEARCH (2009)

Article Biochemistry & Molecular Biology

Structural basis for the recognition of c-Src by its inactivator Csk

Nicholas M. Levinson et al.

Article Rheumatology

The association of the PTPN22 620W polymorphism with Behcet's disease

Vijay Baranathan et al.

ANNALS OF THE RHEUMATIC DISEASES (2007)

Article Genetics & Heredity

Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients

U. Hueffmeier et al.

JOURNAL OF MEDICAL GENETICS (2006)